CG Oncology, Inc. (CGON)
NASDAQ · Healthcare
CG Oncology, Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 4.0M | 1.1M | 204,000 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -190.8M | -114.7M | -55.4M |
| EBITDA | -189.3M | -114.6M | -55.4M |
| Net Income | -161.0M | -88.0M | -48.6M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 77M | 62M | 4M |
CG Oncology, Inc. Income Statement — FAQ
CG Oncology, Inc. (CGON) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGON's income statement history?
The chart and table above show CG Oncology, Inc.'s income statement by year and by quarter, including the growth rate.